13F HOLDINGS REPORT
ANDERA PARTNERS
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001757283-26-000007
Total Value
$176.6M
Positions
5
Other Managers
0
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KESTRA MED TECHNOLOGIES LTD | BEKE | 2,540,106 | $67.4M | 38.14% |
| 2 | MINERALYS THERAPEUTICS INC | MLYS | 1,591,917 | $57.8M | 32.71% |
| 3 | EVOMMUNE INC | EVMN | 1,897,362 | $32.5M | 18.39% |
| 4 | ABIVAX SA | AAVXF | 78,125 | $10.5M | 5.97% |
| 5 | INVENTIVA SA | IVEVF | 1,818,181 | $8.5M | 4.79% |